Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation February 17, 2026 12:30 PM EST
Company Participants
William Anderson – Chairman of the Management Board & CEO
Wolfgang Nickl – CFO & Member of Management Board
Bill Dodero – General Counsel and Senior VP of Law Patents & Compliance
Jost Reinhard – Senior VP & Head of Investor Relations
Conference Call Participants
Richard Vosser – JPMorgan Chase & Co, Research Division
Thibault Boutherin – Morgan Stanley, Research Division
Dietrich Knauth
Laurent Favre – BNP Paribas, Research Division
Alek Ebbeling – UBS Investment Bank, Research Division
Sonia Wind
Charles Pitman – Barclays Bank PLC, Research Division
Sebastian Bray – Joh. Berenberg, Gossler & Co. KG, Research Division
Rajesh Kumar – HSBC Global Investment Research
Presentation
Unknown Executive
Thank you for taking the time to join our Investor and Media call on short notice. One hour ago, we announced a class settlement agreement with plaintiff lawyers in the United States glyphosate litigation. You can find the complete set of materials regarding this agreement on our website. For today’s call, I’m joined by Bill Anderson, CEO of Bayer; Wolfgang Nickl, CFO of Bayer and Bill Dodero, the company’s Head of Litigation and North America Legal. Jost Reinhard, our Head of Investor Relations, is also here with me today to moderate the Q&A part. But before that, Bill will start the call by highlighting what today means and how it fits within our broader strategy. Wolfgang will address the financials, and Bill Dodero will go through specifics of the proposed class settlement.
Now before we begin, please note the cautionary language in our safe harbor statement. And with that, over to you, Bill.
William Anderson
Chairman of the Management Board & CEO
Yes. Thanks for joining, everyone. Today marks an important milestone for the company. Two years ago, we committed to significantly containing
